ABVIX
Price
$16.78
Change
+$0.18 (+1.08%)
Updated
Dec 20 closing price
RMFCX
Price
$54.97
Change
+$0.24 (+0.44%)
Updated
Dec 23 closing price
Ad is loading...

ABVIX vs RMFCX

Header iconABVIX vs RMFCX Comparison
Open Charts ABVIX vs RMFCXBanner chart's image
AB Large Cap Value I
Price$16.78
Change+$0.18 (+1.08%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.97
Change+$0.24 (+0.44%)
VolumeN/A
CapitalizationN/A
ABVIX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABVIX vs. RMFCX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVIX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. ABVIX (438M). RMFCX pays higher dividends than ABVIX: RMFCX (1.69) vs ABVIX (1.28). ABVIX was incepted earlier than RMFCX: ABVIX (20 years) vs RMFCX (23 years). ABVIX is a more actively managed with annual turnover of: 45.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than ABVIX: RMFCX (250) vs ABVIX (2000000). RMFCX annual gain was more profitable for investors over the last year : 11.11 vs. ABVIX (5.47). RMFCX return over 5 years is better than : 37.80 vs. ABVIX (18.53).
ABVIXRMFCXABVIX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years23 years-
Gain YTD4.8209.92149%
Front LoadN/AN/A-
Min. Initial Investment2000000250800,000%
Min. Initial Investment IRAN/AN/A-
Net Assets438M102B0%
Annual Yield % from dividends1.281.6975%
Returns for 1 year5.4711.1149%
Returns for 3 years2.5912.3821%
Returns for 5 years18.5337.8049%
Returns for 10 years29.1959.3649%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA